UNTOLD Ovarian Cancer Unmet Needs Survey

Recruiting

• Conditions: Ovarian Cancer

• Registration Number: NCT07070726
• Lead Sponsor: Masonic Cancer Center, University of Minnesota

Brief Summary

The goal of this study is to comprehensively measure ongoing concerns and unmet needs of individuals living with ovarian cancer. To accomplish this, the UNderstanding The experience of Ovarian cancer - Life after Diagnosis (UNTOLD) study will be conducted using a mixed-methods approach. Ovarian cancer survivors will be enrolled to participate in UNTOLD to complete a one-time survey regarding their experiences. Up to 40 survivors will be subsequently identified to complete a follow-up interview. To ensure these sample sizes, along with a representative sample, a combined recruitment strategy will be employed using the California Cancer Registry (population-based) and recruitment through ovarian cancer advocacy groups.

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-07
• Study First Submitted: 2025-07-08
• Study First Submitted QC: 2025-07-08
• Study Start: 2025-07-10
• Last Update Submitted: 2025-07-16
• Study First Posted: 2025-07-17
• Last Update Posted: 2025-07-20
• Primary Completion: 2026-06-30
• Study Completion: 2028-01-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 2000

Inclusion Criteria

• Ability to read and write in English
• Diagnosed with ovarian cancer (ovarian, primary peritoneal, fallopian tube)

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Supportive Care Needs	Day 1	Composite Supportive Care Needs Survey - Short Form (SCNS-SF34) score minimum: 34, maximum: 170; continuous score; presented as mean and standard deviation.

Secondary Outcome Measures

Name	Time	Method
Quality of Life - Average FACT general total score	Day 1	FACT-General total score minimum 0, maximum 108; continuous score; presented as mean and standard deviation

Trial Locations

Locations (1)

Masonic Cancer Center; 🇺🇸 Minneapolis, Minnesota, United States